SYAPSE INC.

Company Snapshot

Founded: 2008
Entity Type: Private
Region: U.S.
Headquarter: California. U.S.
Key Geographics: U.S., South Korea, Japan
Corporate Address: 303 2nd Street, 5th Floor, Suite 500, San Francisco, California 94107, U.S. Tel.  www.syapse.com

Company Overview

Syapse is developing and marketing informatics for NGS diagnostic applications.

Syapse markets three NGS information applications, Syapse Oncology, Syapse MDx and Syapse PGx. These applications use the tools and technologies in the Syapse Precision Medicine Platform.

These products are end-to-end solutions for laboratories using NGS-based diagnostics. The workflow covers from patient sample received to physician’s report delivered.

Syapse has several partnerships in precision oncology with major pharma companies including with Amgen and Pfizer.

SYAPSE INC. In Reports

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

Discover BCC Research's report on Next-generation Sequencing Market is steadily being integrated into clinical laboratory analysis, testing, and disease diagnostics in healthcare sectors globally.

Precision Medicine: Global Markets

BCC Research Market Report says global market for precision medicine is estimated to increase from $54.2 billion in 2023 to reach $100.5 billion by 2028, at a CAGR of 13.2%.

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

BCC Research Market Report says clinical next-generation sequencing (NGS) should grow from $5.9 billion in 2020 to $22.9 billion by 2025 with a (CAGR) of 31.4%.

Company's Business Segments

  • Solutions : The company offers various solutions to the end customers, such as Raydar, Data Intelligence, Insight Analytics, Applied Experience.

Applications/End User Industries

  • Healthcare
AI Sentiment